The latest closing stock price for NeuroBo Pharmaceuticals as of November 20, 2024 is 2.40.
An investor who bought $1,000 worth of NeuroBo Pharmaceuticals stock at the IPO in 2016 would have $-1,000 today, roughly -1 times their original investment - a -71.50% compound annual growth rate over 8 years.
The all-time high NeuroBo Pharmaceuticals stock closing price was 126419.99 on July 31, 2017.
The NeuroBo Pharmaceuticals 52-week high stock price is 6.75, which is 181.3% above the current share price.
The NeuroBo Pharmaceuticals 52-week low stock price is 2.08, which is 13.3% below the current share price.
The average NeuroBo Pharmaceuticals stock price for the last 52 weeks is 3.83.
An investor who bought $1,000 worth of NeuroBo Pharmaceuticals stock at the IPO in 2016 would have $-1,000 today, roughly -1 times their original investment - a -71.50% compound annual growth rate over 8 years.
The all-time high NeuroBo Pharmaceuticals stock closing price was 126419.99 on July 31, 2017.
The NeuroBo Pharmaceuticals 52-week high stock price is 6.75, which is 181.3% above the current share price.
The NeuroBo Pharmaceuticals 52-week low stock price is 2.08, which is 13.3% below the current share price.
The average NeuroBo Pharmaceuticals stock price for the last 52 weeks is 3.83.